The Emerging Hallmarks of Cancer Metabolism

Cell Metabolism
Natalya N Pavlova, Craig B Thompson

Abstract

Tumorigenesis is dependent on the reprogramming of cellular metabolism as both direct and indirect consequence of oncogenic mutations. A common feature of cancer cell metabolism is the ability to acquire necessary nutrients from a frequently nutrient-poor environment and utilize these nutrients to both maintain viability and build new biomass. The alterations in intracellular and extracellular metabolites that can accompany cancer-associated metabolic reprogramming have profound effects on gene expression, cellular differentiation, and the tumor microenvironment. In this Perspective, we have organized known cancer-associated metabolic changes into six hallmarks: (1) deregulated uptake of glucose and amino acids, (2) use of opportunistic modes of nutrient acquisition, (3) use of glycolysis/TCA cycle intermediates for biosynthesis and NADPH production, (4) increased demand for nitrogen, (5) alterations in metabolite-driven gene regulation, and (6) metabolic interactions with the microenvironment. While few tumors display all six hallmarks, most display several. The specific hallmarks exhibited by an individual tumor may ultimately contribute to better tumor classification and aid in directing treatment.

References

Feb 1, 1989·Archives of Biochemistry and Biophysics·J MárquezI Núñez de Castro
Feb 18, 1969·Biochimica Et Biophysica Acta·L J Fontenelle, J F Henderson
Nov 27, 1967·JAMA : the Journal of the American Medical Association·J M HillR W Hill
Mar 1, 1996·Clinical & Experimental Metastasis·R Martínez-ZaguilánM J Hendrix
Jun 9, 1998·Journal of Cellular Physiology·C L CollinsS F Abcouwer
Jul 10, 1999·The Journal of Biological Chemistry·A BarthelR A Roth
Jan 27, 2000·Cell·D Hanahan, R A Weinberg
Dec 15, 2000·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·J S ConstantM Z Hussain
Feb 28, 2002·Nature Genetics·Ian P M TomlinsonUNKNOWN Multiple Leiomyoma Consortium
Mar 28, 2002·The Journal of Biological Chemistry·Seung-Rock LeeSue Goo Rhee
Apr 30, 2002·Experimental Cell Research·Robert SternBent Formby
Jul 11, 2002·The Journal of Biological Chemistry·Daniel C BerwickJeremy M Tavare
Sep 17, 2002·Cell Death and Differentiation·F FallarinoP Puccetti
Feb 24, 1956·Science·O WARBURG
Oct 1, 2003·Molecular and Cellular Biology·Jeffrey C RathmellCraig B Thompson
Feb 10, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Alexandra Stolzing, Tilman Grune
Aug 3, 2004·Nature Medicine·Bert Vogelstein, Kenneth W Kinzler
Oct 29, 2004·Nature Reviews. Cancer·Eugene W Gerner, Frank L Meyskens
Jun 22, 2005·Biochemical and Biophysical Research Communications·Subir K R ChowdhuryGurmit Singh
Jul 12, 2005·Oncogene·Daniel E BauerCraig B Thompson
Jan 6, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Mihai D NiculescuSteven H Zeisel
Nov 11, 2006·International Journal of Cancer. Journal International Du Cancer·Cheol-Yong YoonBon-Hong Min
Jan 27, 2007·Blood·Karin FischerMarina Kreutz
Feb 3, 2007·Molecular & Cellular Proteomics : MCP·Yue ChenYingming Zhao
Apr 7, 2007·Cancer Metastasis Reviews·Pawel SwietachAdrian L Harris
Apr 28, 2007·Nature Reviews. Drug Discovery·Robert A Casero, Laurence J Marton
May 4, 2007·The Journal of Clinical Investigation·David H Munn, Andrew L Mellor
Jul 4, 2007·The Journal of Cell Biology·Mariia YunevaYuri Lazebnik

❮ Previous
Next ❯

Citations

Feb 22, 2016·International Journal of Hematology·Yajian Jiang, Daisuke Nakada
Mar 12, 2016·Current Opinion in Immunology·Davide BedognettiBarbara Seliger
Apr 12, 2016·Frontiers in Cell and Developmental Biology·Paul C McDonaldShoukat Dedhar
Apr 15, 2016·Cell Metabolism·Deborah C I GoberdhanAdrian L Harris
Apr 28, 2016·Free Radical Biology & Medicine·Marco Sciacovelli, Christian Frezza
Apr 19, 2016·International Journal of Molecular Sciences·Yushuang DingYing Cheng
May 18, 2016·Cell Chemical Biology·Sharon M LouieDaniel K Nomura
May 18, 2016·Experimental Hematology·Ugo TestaElvira Pelosi
Jun 14, 2016·Brain Tumor Pathology·Kenta MasuiPaul S Mischel
Jul 19, 2016·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Kenta MasuiPaul S Mischel
Jul 30, 2016·Cell·Sejal VyasMarcia C Haigis
Aug 2, 2016·Current Opinion in Pharmacology·Francesco Di Virgilio, Paolo Pinton
Jul 31, 2016·Chinese Journal of Cancer·Shuang Liu, Yong-Guang Tao
Aug 12, 2016·Clinical and Translational Medicine·Christoph HerbelVassiliki A Boussiotis
Aug 19, 2016·British Journal of Cancer·Evdokia MichalopoulouJurre J Kamphorst
Aug 24, 2016·Scientific Reports·Agua SobrinoChristopher C W Hughes
Aug 24, 2016·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Zhen-Dong XiaoBoyi Gan
Aug 30, 2016·The Journal of Clinical Investigation·Robert A JonesEldad Zacksenhaus
Sep 14, 2016·Molecular Aspects of Medicine·Xia GaoJason W Locasale
Sep 2, 2016·ELife·Cheng-Wei WangUtpal Banerjee
Sep 27, 2016·Metabolic Engineering·Ziwei Dai, Jason W Locasale
Oct 22, 2016·Biochimica Et Biophysica Acta·R Ariel Igal
Sep 24, 2016·Nature Reviews. Cancer·Michael S NakazawaM Celeste Simon
Sep 30, 2016·Scientific Reports·Illa TeaGuillaume Tcherkez
Oct 4, 2016·Archives of Toxicology·Rosemarie Marchan
Oct 30, 2016·Cell Cycle·Elisabet CuyàsJavier A Menendez
Jul 28, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Yuan ZhaoXuejun Zhang
Dec 3, 2016·Biochemical and Biophysical Research Communications·Hao JiangDongzhi Wei
Dec 8, 2016·Nature Reviews. Molecular Cell Biology·Benjamin R SabariYingming Zhao
Dec 9, 2016·Nature Communications·Beth O Van EmburghAlberto Bardelli
Dec 19, 2016·Drug Discovery Today·Michael J LukeyRichard A Cerione
Dec 21, 2016·Scientific Reports·Caiting YangJianxin Gu
Dec 23, 2016·British Journal of Cancer·Dimitrios Anastasiou
Oct 30, 2016·Journal of Cellular Biochemistry·Thyago Rubens Cardim PiresPatricia Zancan
Jan 25, 2017·Proceedings of the National Academy of Sciences of the United States of America·Hongde LiJason M Tennessen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.